InterCure Ltd. (TLV:INCR)
Israel · Delayed Price · Currency is ILS · Price in ILA 294.40
0.00 (0.00%)
Jun 9, 2026, 1:35 PM IDT
InterCure Market Cap
InterCure has a market cap or net worth of 160.98 million as of June 9, 2026. Its market cap has decreased by -41.33% in one year.
Market Cap
160.98M
Enterprise Value
297.16M
Revenue
270.20M
Ranking
n/a
PE Ratio
n/a
Stock Price
294.40
Market Cap Chart
Since December 16, 2010, InterCure's market cap has increased from 6.41M to 160.98M, an increase of 2,411.92%. That is a compound annual growth rate of 23.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 160.98M | -9.02% |
| Dec 31, 2025 | 176.95M | -34.89% |
| Dec 31, 2024 | 271.76M | 28.77% |
| Dec 31, 2023 | 211.05M | -61.66% |
| Dec 29, 2022 | 550.52M | -40.95% |
| Dec 30, 2021 | 932.28M | 111.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 117.04B |
| Kamada | 1.24B |
| Rekah Pharmaceutical Industry | 121.91M |
| Seach Medical Group | 75.21M |
| Together Pharma | 39.90M |
| Nextage Therapeutics | 13.58M |
| Tikun Olam-Cannbit Pharmaceuticals | 12.65M |
| PsyRX CNS Bio-Tech | 10.74M |